Guardant Health
GH
#1737
Rank
NZ$20.17 B
Marketcap
NZ$153.83
Share price
0.00%
Change (1 day)
145.10%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: NZ$20.17 Billion

As of March 2026 Guardant Health has a market cap of NZ$20.17 Billion. This makes Guardant Health the world's 1737th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$20.17 B-12.63%
2025NZ$23.09 B246.29%
2024NZ$6.66 B28.45%
2023NZ$5.19 B18.31%
2022NZ$4.38 B-70.52%
2021NZ$14.88 B-16.64%
2020NZ$17.85 B63.89%
2019NZ$10.89 B126.72%
2018NZ$4.80 B

End of Day market cap according to different sources

On Mar 9th, 2026 the market cap of Guardant Health was reported to be:

NZ$20.17 Billion
by Nasdaq info icon info icon
NZ$20.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
NZ$3.55 B-82.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ$49.05 B 143.14%๐Ÿ‡บ๐Ÿ‡ธ USA